Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
8,515 total articles
Astera Labs’ connectivity chips are squarely in the path of a massive data-center build-out. Strong revenue growth, meaningful free cash flow, and recent index inclusion have pushed the stock higher, but momentum is pullback-prone. This trade idea lays out a disciplined long entry, targets, and a stop that respect valuation while leaning into conti…
Napco Security (NSSC) is a profitable, debt-free security-equipment designer with solid free cash flow and high return on equity. The market has priced growth expectations into a mid-30s P/E and a >6x price-to-sales multiple, but Napco's push toward an integrated MVP platform (access control, video, and service software) could tilt its revenue mix …
Capitol Federal Financial (CFFN) is not the flashiest bank stock, but its combination of a >4% dividend yield, single-digit price-to-book, and steady cash generation makes it a pragmatic trade for income-minded traders. We outline a mid-term long trade with an entry at $8.60, a stop at $7.40 and a target of $10.25 tied to valuation re-rating and ne…
Market headlines about Copilot adoption and a recent class-action lawsuit have masked Microsoft’s durable cloud economics and cash-generation. At roughly $3.0 trillion market cap and trading near $399, the stock prices in meaningful AI execution risk. For disciplined traders who want asymmetric risk-reward, a mid-term long against a conservative st…
Nvidia remains the AI-era cash machine: $119B in free cash flow, a $5.09T market cap and durable data-center traction. This trade targets continued AI-driven adoption while protecting against cyclicality and geopolitical shocks. Entry $205.00, stop $190.00, target $260.00 over the next 180 trading days.
Donnelley Financial Solutions is converting legacy compliance services into higher-margin software revenue. With free cash flow of $142.8M, EV/EBITDA of 6.7 and analysts on the buy side, the stock at $49.20 offers a tactical long with defined risk controls. This trade targets margin-driven upside as product mix shifts and regulatory demand for stru…
Micron's stock has raced higher on AI-driven memory tightness and rising industry pricing, but much of that upside looks baked into the valuation. Our trade idea buys the company's underappreciated profitability transformation - its outsized free cash flow, low leverage, and capacity to return capital - while protecting against momentum-driven pull…
Nvidia remains the engine of the AI infrastructure cycle: massive free cash flow, industry-leading ROE, and new enterprise partnerships keep demand intact. But the company's scale introduces a different class of risk - high valuation and capital recycling that can mute returns. This trade idea targets a mid-term opportunity to capture AI-led upside…
Nvidia’s core GPU franchise funds a larger pivot: applying accelerated compute to machines that see, move and act. This trade idea buys NVDA to capture adoption of Physical AI across edge devices, robotics, and autonomous vehicle stacks, while respecting a wide range of execution risks. Entry $1180.00, target $1450.00, stop $980.00, horizon: long t…
HPE's networking business (Aruba and edge software) has moved from revenue stabilizer to margin engine. The market still prices HPE as a legacy hardware story; we see a disconnect. Our trade: enter at $17.25, stop $13.50, target $25.00 over a long-term (180 trading days) horizon.
Realty Income (O) offers a near-5% yield, strong occupancy and a long dividend track record. The upside case is driven primarily by multiple expansion and yield compression, not a jump in reported EPS. Trade long at $65.00, target $72.00, stop $60.00 over a long-term (180 trading days) horizon.
Zions Bancorporation looks undervalued relative to earnings and book, supported by core loan growth, a meaningful share-repurchase plan and solid free cash flow. The risk/reward favors a mid-term long trade: entry $69.06, mid-term target $77.40 (45 trading days), stop loss $64.00. Key risks include credit charge-offs, litigation, CRE exposure and r…
TTM Technologies (TTMI) is showing a rare combination of high-growth AI/data-center exposure and defensive aerospace & defense revenue. Strong Q1 results, accretive European acquisitions, and manageable leverage support a mid-term long trade on a pullback. Valuation is rich versus historical norms, so execution and macro cadence matter—we recommend…
UnitedHealth Group (UNH) looks like a clear beneficiary of the market's rotation away from speculative AI infrastructure names. The business mix - dominated by UnitedHealthcare and Optum - is delivering improving margins, strong free cash flow ($19.7B), and a dividend yield above 2%. We lay out a concrete long trade for investors willing to give ma…
Silicon Motion (SIMO) delivered explosive top-line growth in Q1 and is guiding higher for Q2. If MonTitan - a next-gen controller platform the market is expecting - gains traction, revenue and margins could re-accelerate. This trade idea lays out an entry at $270.00, a stop at $235.00 and a target at $350.00 over a mid-term (45 trading days) horizo…
Bloomberg's report that Gemini 3.5 Pro is months behind schedule and a follow-on securities probe have materially increased headline risk for Alphabet. The fundamentals remain strong, but this is a time to trade the sentiment shock: a short trade sized for a 10-trading-day window aiming for a $330 pullback with a tight stop above $355 should captur…
Viper Energy (VNOM) offers a capital-light royalty model, a meaningful dividend yield and recent asset additions that keep cash returns healthy. The stock is a reasonable mid-term buy for income-minded traders, but valuation and operator concentration cap upside. Trade with a clear stop and modest upside targets.
Boeing’s delivery cadence accelerated: 64 jets in June, 171 in Q2 and 314 in H1 — the best first half since 2018. Deliveries convert orders into near-term cash collections, which should improve free cash flow and compress losses heading into the July 28 earnings report. The technical setup is below key moving averages but shows oversold RSI support…
Comfort Systems USA (FIX) sits at the intersection of commercial HVAC and the AI data center build-out. Backlog has ballooned, margins are expanding on higher-margin AI projects, and the company is scaling modular manufacturing to win repeat work. We outline a swing trade entry at $1756.00 with a $2300.00 target and a $1700.00 stop, horizon ~45 tra…
Credo (CRDO) just moved from breakout to pullback, and the fundamentals that powered a >100% run remain intact: fiscal 2026 revenue topped $1.3B, net income surged, and free cash flow is robust. Valuation still demands respect, but improving profitability, generous free cash flow of $407M, and shrinking short interest make this a buy-now trade for …
Tokyo Electron (TOELY) looks positioned to benefit from sustained capital spending across semiconductor fabs, rising demand for deposition/etch/clean processes and a memory-driven capacity squeeze. We favor a long entry near the current level with a mid-to-long-term target of $240 and a disciplined stop below the 50-day support.
AMD just gapped higher after reports of major data center deals with Meta and OpenAI. The fundamentals already show strong AI-era traction — data center revenue is now the bulk of growth, and Q1 2026 revenue reached $10.3B. Valuation is rich, but near-term catalysts and improving free cash flow ($8.57B) justify a tactical, mid-term long for discipl…
Venture Global is trading at ~$14 with strong operational momentum: Q1 strength, new long-term offtakes, and raised EBITDA guidance to $8.2-8.5B. The stock has momentum and technicals on its side, but the company carries heavy leverage and negative free cash flow. This trade idea is a tactical long over the next 45 trading days to capture further r…
Micron shares look actionable after multiple supply-chain indicators shifted from disruption to normalization. With lead times shortening, manufacturing throughput improving, and data-center demand still robust, the risk-reward favors a tactical long. Trade plan below for a mid-term swing with defined entry, stop, and target.
Oric Pharmaceuticals' clinical progress for rinzimetostat and its cash‑rich, debt‑free balance sheet make the stock a constructive swing trade. With Phase 3 dose selected (400 mg QD) and an assertion of favorable economics, shareholders stand to capture disproportionate upside if topline Phase 3 signals are positive. We enter a tactical long at $10…
